Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy

Pediatrics

Volumn 123, Issue 3, 2009, Pages

  Bobo, Janet Kay ^a   Kenneson, Aileen ^b   Kolor, Katherine ^c   Brown, Michael A ^c  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b McKing Consulting Corp   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Cardiovascular disease; Genetic carrier; Muscular dystrophy; Women's health

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHILD CARE; CHOLESTEROL BLOOD LEVEL; ELECTROCARDIOGRAPHY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; SEX DIFFERENCE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ATTITUDE TO HEALTH; CARDIOLOGY; CONGESTIVE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; GENETICS; HEART FAILURE; HEART FUNCTION TEST; HETEROZYGOTE DETECTION; MIDDLE AGED; NEWBORN; PATIENT REFERRAL; PRACTICE GUIDELINE; STATISTICS;

ADULT; CARDIOLOGY; CARDIOMYOPATHY, DILATED; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HEART FUNCTION TESTS; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; REFERRAL AND CONSULTATION; YOUNG ADULT;

EID: 63149131560     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2643     Document Type: Article

References (22)

1. Smith S, Swaiman K. Muscular dystrophies. In: Swaiman K, Ashwal S, eds. Pediatric Neurology. St Louis, MO: Mosby; 1999: 1235-1242
2. Bradley D, Parsons E. Newborn screening for Duchenne muscular dystrophy. Semin Neonatal. 1998;3(3):27-34
3. Comi LI, Nigro G, Politano L, Petretta VR. The cardiomyopthy of Duchenne/Becker consultands. Int J Cardiol. 1992;34(3): 297-305
4. Grain L, Cortina-Borja M, Forfar C, Hilton-Jones D, Hopkin J, Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord. 2001;11(2):186-191
5. Hoogerwaard E, Bakker E, Ippel P, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study. Lancet. 1999;353(9170):2116-2119
6. Bushby K, Mutoni F, Bourke JP. 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. Neuromuscul Disord. 2003;13(2):166-172
7. Politano L, Nigro V, Nigro G, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA. 1996;275(17):1335-1338
8. Holloway S, Wilcox D, Wilcox A, et al. Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart. 2008;94(5):633-636
9. American Academy of Pediatrics, Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116(6):1569-1573
10. Mosca L, Ferris A, Fabunmi R, et al. Tracking women's awareness of heart disease: an American Heart Association National Study. Circulation. 2004;109(5):573-579
11. Lethbridge-Cejku M, Rose D, Vickerie J. Summary health statistics for US adults: National Health Interview Survey, 2004. Vital Health Stat 10. 2006;(228):1-107
12. National Center for Health Statistics. National Health Interview Survey, 2004: Data File Documentation [machine readable data file and documentation]. Hyattsville, MD: National Center for Health Statistics; 2005
13. Centers for Disease Control and Prevention. 2004 Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: Centers for Disease Control and Prevention; 2004
14. National Center for Health Statistics. National Health and Nutrition Examination Survey 2003-2004, Documentation, Codebook, and Frequencies: SP Questionnaire Component: Blood Pressure Questionnaire Data. Hyattsville, MD: National Center for Health Statistics; 2006
15. Ali NS. Prediction of coronary heart disease preventive behaviors in women: a test of the health belief model. Women Health. 2002;35(1):83-96
16. Miller LA, Romitti PA, Cunniff C, et al. The Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol. 2006;76(11):793-797
17. National Center for Health Workforce Analysis, Bureau of Health Professions. User Documentation for the Area Resource File (ARF), 2005 Release. Washington, DC: Health Resources and Services Administration; 2007
18. Mendell JR, Buzin CH, Feng J, et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurolgy. 2001;57(4):645-650
19. Prior T, Bridgeman S. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn. 2005;7(3):317-326
20. Dent KM, Dunn DM, von Niederhausern AC, et al. Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A. 2005;134(3):295-298
21. Todorova A, Todorov T, Georgieva B, et al. MLPA analysis/complete sequencing of the DMD gene in a group of Bulgarian Duchenne/Becker muscular dystrophy patients. Neuromuscul Disord. 2008;18(8):667-670
22. Ashton E, Yau S, Deans Z, et al. Simultaneous mutation scanning for gross deletions, duplications and point mutation in the DMD gene. Eur J Hum Genet. 2008;16(1):53-61